In Silico Design of MDM2-Targeting Peptides from a Naturally Occurring Constrained Peptide

ChemMedChem. 2019 Oct 4;14(19):1710-1716. doi: 10.1002/cmdc.201900366. Epub 2019 Sep 18.

Abstract

Naturally occurring constrained peptides are frequently used as scaffolds for bioactive peptide grating due to their high stability. Here, we used in silico methods to design several constrained peptides comprising a scorpion toxin scaffold, a MDM2 binding epitope, and a cluster of positively charged residues. The designed peptides displayed varied binding affinity to MDM2 despite differing by only one or two residues. One of the peptides, SC426, had nanomolar binding affinity (KD =6.6±2.6 nm) to MDM2, and exhibited stronger inhibitory activity on the proliferation of HCT116 cells (p53-wild type) and SW480 cells (p53-mutant) than that of nutlin-3a. Binding mode analysis of the designed peptide at MDM2 suggests that the conserved "FWL" epitope was buried in the hydrophobic binding pocket, and the residues located at the periphery of the binding site contributed to the high binding affinity of SC426. Overall, in silico design of miniproteins with therapeutic potential through epitope grafting to the naturally occurring constrained peptide is an effective strategy.

Keywords: In silico design; MDM2; activity assays; p53; peptide toxin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology
  • Cell Line, Tumor
  • Computer Simulation
  • Drug Screening Assays, Antitumor
  • Humans
  • Imidazoles / pharmacology
  • Peptides / chemistry*
  • Peptides / pharmacology
  • Piperazines / pharmacology
  • Proto-Oncogene Proteins c-mdm2 / antagonists & inhibitors*

Substances

  • Antineoplastic Agents
  • Imidazoles
  • Peptides
  • Piperazines
  • nutlin 3
  • Proto-Oncogene Proteins c-mdm2